10 Most-Read Stories of 2016 So Far

Ixoreal Biomed highlights an exploratory placebo-controlled study of SRI-81 Shatavari, alone and combined with KSM-66 Ashwagandha, published in the International Journal of Women’s Health.

Clinical research moves beyond compliance, focusing on smarter trial design, risk-based quality, and “evidence engineering” to deliver decisive, decision-ready results.

The four-formula line is Olly’s second retailer-exclusive launch this year, following the launch of a probiotic range in April.

The company’s new division offers bovine, porcine, ovine, poultry glandulars for supplements, pet food, and animal feed, highlighting a full QA document package.

Why responsible innovation means asking whether yesterday's formulations still reflect today's best science—not just launching the next new ingredient.

A new Walmart-exclusive supplement from Lemme joins a fast-growing, category of products marketed around the body's natural GLP-1 production.

BENEO's Denisse Colindres discusses how the fibermaxxing trend is evolving beyond "more fiber" to fiber diversity and layering, and what that shift means for formulation, claims, and category opportunity.

TriNutra is presenting new data on its standardized black seed oil ingredient at SupplySide Global, adding to a growing body of research on how gut bacteria and the body's stress response may influence each other.